Story

ConvaTec Initiated with 'Buy' Rating at Kepler Cheuvreux on Growth Recovery Hopes

ENTHMSVIIDZHZH-TWJAKOHI
Aug 27, 20261 min read
ConvaTec Initiated with 'Buy' Rating at Kepler Cheuvreux on Growth Recovery Hopes
Text size
Background

Kepler Cheuvreux initiated coverage of ConvaTec Group PLC (LON:CTEC) with a "Buy" rating, setting a price target of 286 pence. The brokerage's investment thesis is built on the view that the medical-products maker has successfully navigated its recent operational difficulties and is entering a new phase of growth.

The Analyst Case

According to a note from Kepler, ConvaTec's growth profile is set to broaden following the reset of its InnovaMatrix platform. The firm anticipates that fiscal year 2027 will provide investors with much clearer visibility into the company's sales and capital expenditure.

Kepler's positive outlook is supported by several key projections:

  • An expected growth rate of around 7%.
  • A low-teens compound annual growth rate (CAGR) in earnings per share (EPS).
  • Improving operating margins moving into the mid-20% range.
  • Stronger free-cash-flow generation.

Valuation and Market View

Sample IUX Markets – In-articleAd

The central argument from Kepler is that ConvaTec's stock is currently undervalued, as investors are still treating it as a turnaround story. However, the brokerage contends that the company's operating performance has already begun to normalize and that the focus should now be on demonstrating "repeatable execution."

Kepler believes the projected improvements in growth and profitability are sufficient to justify a higher valuation multiple for the stock. The firm sees the company's restructuring efforts and improving performance as key drivers for margin expansion and cash flow.

Market Reaction

Following the initiation, shares of ConvaTec rose modestly in London trading, last seen up 0.4% at 228.4 pence. The move slightly underperformed the broader FTSE 250 index, which was trading approximately 0.6% higher on the day.

Read next

More on Stocks
Back to latest news

LATEST